COVID Vaccine Stocks: How Strong Is BioNTech's Financial Position?

BioNTech (NASDAQ: BNTX) has now hit the big time. Its first approved product, COVID-19 vaccine BNT162b2, is on its way to quickly becoming a mega-blockbuster success for the biotech. But how strong is BioNTech's financial position right now?

In this Motley Fool Live video recorded on Jan. 13, 2021, Healthcare and Cannabis Bureau Chief Corinne Jurney Cardina and Fool.com writer Keith Speights looked at the company's cash position and income statement.

Continue reading

Source Fool.com